[1] |
李海波,符洪源,陆桐宇,等.肝移植领域2017年度重要进展盘点[J].器官移植,2018, 9(1):41-50, 82.
|
[2] |
王正昕,钦伦秀.肝移植术后并发症的防治现状及进展[J].中国普外基础与临床杂志,2018, 25(9):1025-1030.
|
[3] |
邵文雨,黄新立,周浩明,等.公民器官捐献供体质量对肝移植术后受体生存率的影响及其感染高危因素分析[J].临床外科杂志,2018, 26(12):913-917.
|
[4] |
Corman Dincer P, Tore Altun G, Birtan D, et al. Incidence and risk factors for systemic infection in deceased donors[J]. Transplant Proc, 2019, 51(7):2195-2197.
|
[5] |
Echenique IA, Ison MG. Update on donor-derived infections in liver transplantation[J]. Liver Transpl, 2013, 19(6):575-585.
|
[6] |
Lumbreras C, Sanz F, González A, et al. Clinical significance of donor-unrecognized bacteremia in the outcome of solid-organ transplant recipients[J]. Clin Infect Dis, 2001, 33(5):722-726.
|
[7] |
Abad CL, Lahr BD, Razonable RR. Epidemiology and risk factors for infection after living donor liver transplantation[J]. Liver Transpl, 2017, 23(4):465-477.
|
[8] |
Harrison J, Harrison M, Doria C. Hepatic artery pseudoaneurysm following orthotopic liver transplantation: increasing clinical suspicion for a rare but lethal pathology[J]. Ann Transplant, 2017(22):417-424.
|
[9] |
Takeda K, Sawada Y, Kumamoto T, et al. Severe sepsis after living donor liver transplantation: risk factors and outcomes[J]. Transplant Proc, 2016, 48(6):2124-2129.
|
[10] |
Wang Y, Gu Y, Huang F, et al. Risk factors for sepsis based on sepsis-3 criteria after orthotopic liver transplantation[J]. Mediators Inflamm, 2018:8703172.
|
[11] |
Ye QF, Zhou W, Wan QQ. Donor-derived infections among Chinese donation after cardiac death liver recipients[J]. World J Gastroenterol, 2017, 23(31):5809-5816.
|
[12] |
Escolà-Vergé L, Los-Arcos I, José González-López J, et al. Successful liver transplantation despite donor-transmitted ESBL-producing Klebsiella pneumoniae infection: case report and review of the literature[J]. Transpl Infect Dis, 2017, 19(5):e12743.
|
[13] |
Galvão LM, Oliveira APR, Ibanês AS, et al. Fatal case of donor-derived colistin-resistant carbapenemase-producing Klebsiella pneumoniae transmission in cardiac transplantation[J]. Braz J Infect Dis, 2018, 22(3):235-238.
|
[14] |
Varotti G, Dodi F, Marchese A, et al. Fatal donor-derived carbapenem-resistant Klebsiella pneumonia infection in a combined kidney-pancreas transplantation[J]. Case Rep Transplant, 2016: 7920951.
|
[15] |
Giani T, Conte V, Mandalà S, et al. Cross-infection of solid organ transplant recipients by a multidrug-resistant Klebsiella pneumoniae isolate producing the OXA-48 carbapenemase, likely derived from a multiorgan donor[J]. J Clin Microbiol, 2014, 52(7):2702-2705.
|
[16] |
Mularoni A, Bertani A, Vizzini G, et al. Outcome of transplantation using organs from donors infected or colonized with carbapenem-resistant gram-negative bacteria[J]. Am J Transplant, 2015, 15(10):2674-2682.
|
[17] |
Ison MG, Grossi P, AST Infectious Diseases Community of Practice. Donor-derived infections in solid organ transplantation[J]. Am J Transplant, 2013, 13 Suppl 4:22-30.
|
[18] |
Ruiz P, Gastaca M, Gonzalez J, et al. Incidence and clinical relevance of bacterial contamination in preservation solution for liver transplantation[J]. Transplant Proc, 2009, 41(6):2169-2171.
|
[19] |
Sifri CD, Ison MG. Highly resistant bacteria and donor-derived infections treading in uncharted territory[J]. Transpl Infect Dis, 2012, 14(3):223-228.
|
[20] |
Martins N, Martins IS, De Freitas WV, et al. Severe infection in a lung transplant recipient caused by donor-transmitted carbapenem-resistant Acinetobacter baumannii[J]. Transpl Infect Dis, 2012, 14(3): 316-320.
|